74 participants
Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-10
- Start Date:
- 2017-07-30
- Completion:
- 2027-12-31
Conditions
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
Interventions
- PROCEDURE
- DRUG
- BIOLOGICAL
No Results Yet